Paper Review Records
全部论文审稿周期
20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
244
天
The SQSTM1 L341V Variant Associated With Sporadic ALS Promotes the Accumulation of Enlarged Ubiquitin‐Positive SQSTM1 Bodies
作者
Kento Shimakura; Akira Oka; Haruka Yudahira; Yutaro Hama; Asako Otomo; Shinji Hadano展开收起
作者单位
1. Molecular Neuropathobiology Laboratory, Department of Physiology Tokai University School of Medicine Isehara Kanagawa Japan; 2. Department of Molecular Life Sciences Tokai University School of Medicine Isehara Kanagawa Japan; 3. The Institute of Medical Sciences Tokai University Isehara Kanagawa Japan; 4. Micro/Nano Technology Center Tokai University Hiratsuka Kanagawa Japan展开收起
158
天
FOXO1 Is Required for Growth and Viability of Cancer‐Associated Fibroblasts in Human Breast Carcinomas
作者
Takumi Koyama; Tetsuo Kobayashi; Yoshihiro Mezawa; Weibo Gao; Kaishi Yamada; Kazunari Yamashita; Zixu Wang; Yu Koyama; Masaaki Abe; Reo Maruyama; Liying Yang; Hiroaki Daitoku; Akiyoshi Fukamizu; Atsushi Takano; Yohei Miyagi; Tomoyuki Yokose; Toshinari Yamashita; Keisuke Sugahara; Hiroyuki Seimiya; Yataro Daigo; Akira Katakura; Akira Orimo展开收起
作者单位
1. Department of Oral Pathobiological Science and Surgery Tokyo Dental College Tokyo Japan; 2. Department of Pathology and Oncology Juntendo University Faculty of Medicine Tokyo Japan; 3. Department of Molecular Pathogenesis Juntendo University Graduate School of Medicine Tokyo Japan; 4. Division of Cancer Epigenomics, Cancer Institute Japanese Foundation for Cancer Research Tokyo Japan; 5. Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance University of Tsukuba Ibaraki Japan; 6. Research Platform Office, Institute of Medical Science The University of Tokyo Tokyo Japan; 7. Department of Medical Oncology and Cancer Center, and Center for Advanced Medicine Against Cancer Shiga University of Medical Science Otsu Japan; 8. Molecular Pathology and Genetics Division Kanagawa Cancer Center Research Institute Yokohama Japan; 9. Department of Pathology Kanagawa Cancer Center Yokohama Japan; 10. Department of Breast Surgery and Oncology Kanagawa Cancer Center Yokohama Japan; 11. Division of Molecular Biotherapy, Cancer Chemotherapy Center Japanese Foundation for Cancer Research Tokyo Japan; 12. Faculty of Health Sciences, Graduate School of Medicine Juntendo University Tokyo Japan展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天